— Know what they know.
Not Investment Advice
Also trades as: TEVA (NYSE) · $vol 221M · TEVA.TA (TLV) · $vol 41M

TEVJF OTC

Teva Pharmaceutical Industries Limited
1W: +18.5% 1M: +5.3% 3M: +28.5% YTD: +36.2% 1Y: +172.2% 3Y: +392.8% 5Y: +233.2%
$38.98
+1.98 (+5.35%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 64 · $45.4B mcap · 1.11B float · 0.0000% daily turnover · Short 88% of daily vol

📊 Key Metrics

TTM
$17B
Revenue
+4.1% YoY
$716M
Net Income
+553.1% YoY
$1B
Free Cash Flow
+18.4% YoY
52.0%
Gross Margin
-5.6%
Op. Margin
-13.9%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE9.8%
ROA1.8%
ROIC12.3%

Valuation

P/E63.2
P/B6.0
EV/EBITDA16.5

Leverage

Debt/Equity2.18
Current Ratio0.88
Interest Cov.2.7x

Quality Scores

Piotroski F7/9
Altman Z0.71
Beneish M-2.72

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms